Wegovy is approved for chronic weight management, which affects which insurance benefits apply, while Ozempic is approved for type 2 diabetes, meaning the same medication can carry a very different price tag depending on the indication billed
Both Semaglutide GLP-1 and Tirzepatide are very effective in supporting weight loss programs due to the effects that they have on the digestive system to slow down digestion, resulting in the body thinking that it is fuller for longer
The members Digital Twin collects continuous data, including CGM readings, daily weigh-ins, meal logs, activity, and sleep
Important Safety Information Do not use AOD-9604 if you: Have a known hypersensitivity to growth hormone fragments or any component of the formulation Have active malignancy (cancer that is currently being treated or monitored) Are pregnant or breastfeeding (insufficient safety data) Have a history of severe allergic reactions to peptide therapies Common side effects (typically mild and transient): Headache, mild gastrointestinal disturbances (flatulence, mild diarrhea at higher doses), upper respiratory tract symptoms, injection site reactions (redness, mild discomfort) Seek medical attention if you experience: Signs of allergic reaction (hives, difficulty breathing, swelling of face or throat), persistent gastrointestinal symptoms, unexplained significant changes in energy, mood, or physical symptoms Clinical Safety Data Safety studies involving approximately 900 participants across six randomized controlled trials documented that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo across most parameters
Available ADI-SPA-542 Datasheet Manual SDS CofA Already have an account
